Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00694577 · ClinicalTrials.gov registry record · NA
Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 324
- Enrollment target
NCT00694577: Completed NA study, sponsored by Massachusetts General Hospital.
NCT00694577 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 324 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00694577, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 324 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of partial breast irradiation in participants with early invasive or non-invasive breast cancer.
Primary Outcome
Feasibility and local control of early breast cancer treated by partial breast irradiation using different radiation doses. Number of patients who completed partial breast irradiation was used to determine feasibility.
Interventions
- RADIATION Partial Breast Irradiation using 32 Gy / 8 fractions
- RADIATION Partial Breast Irradiation using 36 Gy / 9 fractions
- RADIATION Partial Breast Irradiation using 40 Gy /10 fractions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2003-09 |
| Est. Completion | 2021-06 |
| Phase | NA |
What the finished NCT00694577 record still lists
NCT00694577 is an interventional study that assigns participants to a tested intervention. The registered 324 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 3 interventions - of which Partial Breast Irradiation using 32 Gy / 8 fractions is the first listed.
NCT00694577 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00694577 about?
NCT00694577 is a clinical study titled "Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer". The purpose of this study is to determine the feasibility of partial breast irradiation in participants with early invasive or non-invasive breast cancer.
What is the current status of trial NCT00694577?
This trial is currently completed. It is a NA study. The enrollment target is 324 participants. The study started on 2003-09. Estimated completion is 2021-06.
What interventions are being tested in trial NCT00694577?
The interventions under investigation include: Partial Breast Irradiation using 32 Gy / 8 fractions (RADIATION), Partial Breast Irradiation using 36 Gy / 9 fractions (RADIATION), Partial Breast Irradiation using 40 Gy /10 fractions (RADIATION).
Who is sponsoring clinical trial NCT00694577?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00694577's enrollment target sits among peer trials
324 312th of 2000 higher than 1,686 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04164173 · 324 participants · NA
Hyperinflation Respiratory Therapies in Cardiac Surgery Patients
- NCT04708054 · 324 participants · Phase 2
Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- NCT05261399 · 324 participants · Phase 3
Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment
- NCT05353322 · 324 participants · NA
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia